JP5086612B2 - Emulsified skin external preparation containing hydroxyapatite-treated powder - Google Patents
Emulsified skin external preparation containing hydroxyapatite-treated powderInfo
- Publication number
- JP5086612B2 JP5086612B2 JP2006308597A JP2006308597A JP5086612B2 JP 5086612 B2 JP5086612 B2 JP 5086612B2 JP 2006308597 A JP2006308597 A JP 2006308597A JP 2006308597 A JP2006308597 A JP 2006308597A JP 5086612 B2 JP5086612 B2 JP 5086612B2
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- skin
- powder
- acid
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims description 94
- 238000002360 preparation method Methods 0.000 title claims description 54
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims description 31
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims description 31
- -1 acyl lactic acid Chemical compound 0.000 claims description 71
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 34
- 239000000194 fatty acid Substances 0.000 claims description 34
- 229930195729 fatty acid Natural products 0.000 claims description 34
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 23
- 150000004665 fatty acids Chemical class 0.000 claims description 23
- 239000004310 lactic acid Substances 0.000 claims description 20
- 235000014655 lactic acid Nutrition 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 239000003945 anionic surfactant Substances 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- QMGGUIASDZZMHS-UHFFFAOYSA-N Stearoyllactic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C(O)=O QMGGUIASDZZMHS-UHFFFAOYSA-N 0.000 claims description 4
- 229920000223 polyglycerol Polymers 0.000 claims description 4
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 229910000077 silane Inorganic materials 0.000 claims description 3
- 239000002345 surface coating layer Substances 0.000 claims 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 19
- 239000002537 cosmetic Substances 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 19
- 239000011247 coating layer Substances 0.000 description 17
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 125000002252 acyl group Chemical group 0.000 description 9
- 239000010445 mica Substances 0.000 description 9
- 229910052618 mica group Inorganic materials 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 238000012423 maintenance Methods 0.000 description 8
- 239000004408 titanium dioxide Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- 239000000454 talc Substances 0.000 description 7
- 229910052623 talc Inorganic materials 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 229940071136 stearoyl glutamate Drugs 0.000 description 5
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 238000004381 surface treatment Methods 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 159000000007 calcium salts Chemical class 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003910 behenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical class [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- JWGGSJFIGIGFSQ-UHFFFAOYSA-N N-dodecanoylglycine Chemical compound CCCCCCCCCCCC(=O)NCC(O)=O JWGGSJFIGIGFSQ-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- GMGONJRHVPHAPD-UCLFVTEUSA-H dialuminum;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [Al+3].[Al+3].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O GMGONJRHVPHAPD-UCLFVTEUSA-H 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 150000002169 ethanolamines Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- XLTMWFMRJZDFFD-UHFFFAOYSA-N 1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1Cl XLTMWFMRJZDFFD-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- QWUAEFUHELCUHK-UHFFFAOYSA-N 2-hydroxy-2-methylicosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(C)(O)C(O)=O QWUAEFUHELCUHK-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- PISDZOQJJGXAME-UHFFFAOYSA-N C(C(O)C)(=O)OCCCCCCCCCCCCCCCC.[Na] Chemical group C(C(O)C)(=O)OCCCCCCCCCCCCCCCC.[Na] PISDZOQJJGXAME-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- XNYQNWHBYNTXMF-UQKRIMTDSA-L [Zn+2].C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-] Chemical compound [Zn+2].C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-] XNYQNWHBYNTXMF-UQKRIMTDSA-L 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- BRGKNMJAFJDJNH-QVAZYVOZSA-H dialuminum;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Al+3].[Al+3].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O.CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O BRGKNMJAFJDJNH-QVAZYVOZSA-H 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 description 1
- KNYAZNABVSEZDS-UHFFFAOYSA-M sodium;2-octadecanoyloxypropanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C([O-])=O KNYAZNABVSEZDS-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003698 vitamin B derivatives Chemical class 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- QVLLDPBOWNCACO-BDQAORGHSA-L zinc;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O QVLLDPBOWNCACO-BDQAORGHSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、皮膚外用剤に関し、更に詳細には、ヒドロキシアパタイト処理粉体を含有する化粧料に好適な皮膚外用剤に関する。 The present invention relates to an external preparation for skin, and more particularly to an external preparation for skin suitable for a cosmetic containing a hydroxyapatite-treated powder.
化粧料などの皮膚外用剤において、乳化剤形を適用することは、油溶性成分と、水溶性成分の両方を同一製剤に製剤化出来る点で非常に有用であり、特に、化粧料のように有効成分を多種含有する商品では、この有用性は非常に大きなものとなる。又、乳化剤形は通常安定な水−油界面を有するので、この界面を利用して、二酸化チタン、酸化亜鉛、酸化鉄、マイカ、チタンマイカ、タルクなどの無機系の粉体成分を安定に分散する分散媒にも使用される。特に、無機系の粉体類は金属酸化物を主成分とするため、油性成分のみ、或いは、水性成分のみの系では、その比重の大きさ故に、容易に沈降してしまうが、界面に配位することにより、安定に分散状態を保つことが出来る。又、その様な要件、即ち、しっかりとした界面構造を形成する剤形でなければ無機系の粉体を含有する乳化製剤の剤形として適さないとも言える。この様な界面構造は、従来の技術においては、脂肪酸石鹸と高級アルコールによって形成される構造や、有機変性ヘクトライトと多価アルコールと水によって形成される網目構造が利用されてきた。しかしながら、有機変性ヘクトライトと多価アルコールの構造は油中水剤形においてのみ形成されるものであり、この系を採用する限り、油中水乳化剤形ののびの重さと、仕上がりの脂っぽさの軛からは逃れ難い現状であったし、脂肪酸石鹸と高級アルコールの作る構造を採用すると、安定性そのものは良好であっても、化粧仕上がりが脂肪酸石鹸によって、容易に再乳化・再分散され、崩れやすい欠点を呈する場合が少なくなかった。脂肪酸石鹸は乳化性に優れるため、化粧持ちにおいては両刃の刃になりかねない要素を有していた。 In skin external preparations such as cosmetics, it is very useful to apply an emulsifier form in that both oil-soluble ingredients and water-soluble ingredients can be formulated into the same formulation. For commercial products containing various ingredients, this utility is very large. In addition, since the emulsifier form usually has a stable water-oil interface, inorganic powder components such as titanium dioxide, zinc oxide, iron oxide, mica, titanium mica, and talc are stably dispersed using this interface. It is also used as a dispersion medium. In particular, since inorganic powders are mainly composed of metal oxides, in the case of only oily components or only water-based components, they settle easily due to their large specific gravity, but are distributed at the interface. The dispersion state can be stably maintained by positioning. Moreover, such a requirement, that is, also not suitable as a dosage form of an emulsion formulation containing a firm powder inorganic If not form a dosage form the interface structure can be said. In such conventional interface structures, a structure formed by fatty acid soap and higher alcohol and a network structure formed by organically modified hectorite, polyhydric alcohol and water have been used in the prior art. However, the structure of organically modified hectorite and polyhydric alcohol is formed only in the water-in-oil dosage form, and as long as this system is adopted, the weight of the water-in-oil emulsifier and the finished fat it was WESTERN shaped flame escaped from the yoke, when adopting the structure to make the fatty acid soap and fatty alcohol, stability itself be a good, by decorative finish fatty acid soap, & readily redispersible re In many cases, it was dispersed and exhibited the disadvantage of being easily broken. Since the fatty acid soap is excellent in emulsifying properties, it has an element that can be a double-edged blade when having a makeup.
前記の高級アルコール・脂肪酸石鹸構造や有機変性ヘクトライト・多価アルコール・水構造に代わる新規の乳化構造系としては、無機系の粉体の含有量の少ない乳化剤形においては、ステアロイル乳酸とアシル化ポリグリセリンの作る乳化系が粉体分散性と、その安定性に優れる系を創出することが知られている(例えば、特許文献1を参照)。しかしながら、この様な系に於いても、無機系の粉体量が多くなると、均一分散性が損なわれることが本発明者により見いだされている。又、この系に於いても汗や皮脂に対する化粧膜の耐性(皮膚接着維持性)を高める必要も存している。この様な化粧崩れには、脂肪酸及び脂肪酸とアルカリとが反応して形成された脂肪酸石鹸が重要な役割を果たしており、脂肪酸をトラップすることにより化粧持ちが向上できる技術が既に知られている(例えば、特許文献2を参照)。しかしながら、乳化系では前記の状況から、この技術を適用するのが困難な状態にあった。 As a new emulsification structure system to replace the higher alcohol / fatty acid soap structure and organic modified hectorite / polyhydric alcohol / water structure, stearyl lactic acid and acylation are used in the emulsifier form with a small content of inorganic powder. It is known that an emulsifying system made of polyglycerin creates a system having excellent powder dispersibility and stability (see, for example, Patent Document 1). However, even in such a system, the present inventors have found that uniform dispersion is impaired when the amount of inorganic powder increases. Also in this system, there is a need to increase the resistance of the cosmetic film (skin adhesion maintenance) to sweat and sebum. Fatty acid soaps formed by reaction of fatty acids and fatty acids with alkalis play an important role in such makeup disintegration, and a technology that can improve makeup lasting by trapping fatty acids is already known ( For example, see Patent Document 2). However, in the emulsification system, it was difficult to apply this technique due to the above situation.
一方、ステアロイル乳酸等のアシル乳酸とアシル化ポリグリセリンの乳化構造系については、安定な水中油乳化系を作ることが知られている(例えば、特許文献3、特許文献4、特許文献5、特許文献6、特許文献7、特許文献8、特許文献9を参照)し、アシル乳酸とアニオン界面活性剤とを組み合わせて乳化する技術もすでに知られている(例えば、特許文献10)が、アシル乳酸とアシル化ポリグリセリンと硫酸系アニオン界面活性剤との組み合わせは知られていないし、無機系の粉体との組み合わせも特許文献1以外は知られていない。加えて、特許文献11や特許文献12に開示されている、ヒドロキシアパタ
イト処理粉体(例えば、特許文献11、特許文献12を参照)を共存させて、皮膚に基源を発する脂肪酸及び/又はその塩を除去することにより、化粧持ちが格段に向上することも知られていない。
On the other hand, it is known to produce a stable oil-in-water emulsion system for an emulsion structure system of acyl lactic acid such as stearoyl lactic acid and acylated polyglycerin (for example, Patent Document 3, Patent Document 4, Patent Document 5, Patent Document 6, Patent Document 7, Patent Document 8, and Patent Document 9), and a technique of emulsifying a combination of acyl lactic acid and an anionic surfactant is already known (for example, Patent Document 10). A combination of acylated polyglycerin with a sulfate-based anionic surfactant is not known, and a combination with inorganic powder is not known except for Patent Document 1. In addition, the fatty acid which originates in the skin and / or its coexistence with hydroxyapatite-treated powder (for example, see Patent Document 11 and Patent Document 12) disclosed in Patent Document 11 and Patent Document 12 It is not known that the removal of salt significantly improves the makeup life.
本発明は、この様な状況下為されたものであり、水中油乳化剤形の無機系の粉体を含有する皮膚外用剤において、その皮膚接着維持性を向上せしめる技術を提供することを課題とする。 The present invention has been made under such circumstances, and it is an object of the present invention to provide a technique for improving the skin adhesion maintenance in an external preparation for skin containing an oil-in-water emulsifier type inorganic powder. To do.
この様な状況に鑑みて、本発明者らは、水中油乳化剤形の無機系の粉体を含有する皮膚
外用剤において、その皮膚接着維持性を向上せしめる技術を求めて、鋭意研究努力を重ねた結果、1)アシル乳酸及び/又はその塩0.05〜5質量%と、2)アシル化ポリグリセリン0.1〜10質量%と、3)硫酸系アニオン界面活性剤として脂肪酸グリセリン硫酸塩0.05〜0.5質量%と、4)無機系の粉体とを含有する水中油乳化剤形の皮膚外用剤に、粉体としてヒドロキシアパタイト被覆粉体を含有せしめることにより、この様な皮膚外用剤が得られることを見いだし、発明を完成させるに至った。即ち、本発明は以下に示す通りである。
(1)1)アシル乳酸及び/又はその塩0.05〜5質量%と、2)アシル化ポリグリセリン0.1〜10質量%と、3)硫酸系アニオン界面活性剤として脂肪酸グリセリン硫酸塩0.05〜0.5質量%と、4)表面が親油化処理されていてもよい無機系の粉体5〜30質量%とを含有する水中油乳化剤形の皮膚外用剤において、前記無機系の粉体としてヒドロキシアパタイトを含む被覆層を表面に有する無機系の粉体を含有することを特徴とする、皮膚外用剤。
(2)前記アシル乳酸が、ステアロイル乳酸であることを特徴とする、(1)に記載の皮膚外用剤。
(3)前記親油化処理されていてもよい無機系の粉体が、N−アシルアミノ酸塩被覆処理、メチルハイドロジェンポリシロキサン焼付処理及びアルキルアルコキシシランによるシランカップリング処理から選択される少なくとも1種の表面処理が施されたものであることを特徴とする、(1)又は(2)に記載の皮膚外用剤。
(4)前記アシル化ポリグリセリンが、デカグリセリンペンタステアレートであることを特徴とする、(1)〜(3)の何れかに記載の皮膚外用剤。
(5)更に、アルキレンオキシド変性シリコーン及び/又はグリセリン変性シリコーンを含有することを特徴とする、(1)〜(4)の何れかに記載の皮膚外用剤。
(6)脂肪酸フリーであることを特徴とする、(1)〜(5)の何れかに記載の皮膚外用剤。
In view of such a situation, the present inventors have made intensive research efforts in search of a technique for improving the skin adhesion maintenance of an external preparation for skin containing an oil-in-water emulsifier type inorganic powder. As a result, 1) acyl lactic acid and / or a salt thereof 0.05 to 5% by mass, 2) acylated polyglycerol 0.1 to 10% by mass, and 3) fatty acid glycerol sulfate 0 as a sulfate anionic surfactant By adding a hydroxyapatite-coated powder as a powder to an oil- in- water emulsifier type skin external preparation containing 0.05 to 0.5% by mass and 4) an inorganic powder, such a skin external application The inventors have found that an agent can be obtained and have completed the invention. That is, the present invention is as follows.
(1) 1) acyl lactic acid and / or its salt 0.05-5 mass%, 2) acylated polyglycerin 0.1-10 mass%, 3) fatty acid glycerin sulfate 0 as sulfate anionic surfactant In the skin external preparation in the form of an oil-in-water emulsifier containing 0.05 to 0.5% by mass and 4) 5 to 30% by mass of an inorganic powder whose surface may be subjected to lipophilic treatment, of which contains a powder of inorganic having a coating layer comprising hydroxyapatite on the surface as a powder you wherein external skin preparation.
(2) The external preparation for skin according to (1), wherein the acyl lactic acid is stearoyl lactic acid.
(3) The inorganic powder which may be subjected to lipophilic treatment is at least one selected from N-acyl amino acid salt coating treatment, methylhydrogenpolysiloxane baking treatment and silane coupling treatment with alkylalkoxysilane. The skin external preparation according to (1) or (2), wherein the surface treatment of the seed is performed.
(4) The external preparation for skin according to any one of (1) to (3), wherein the acylated polyglycerin is decaglycerin pentastearate .
( 5 ) The skin external preparation according to any one of (1) to ( 4) , further comprising an alkylene oxide-modified silicone and / or a glycerin-modified silicone .
( 6 ) The external preparation for skin according to any one of (1) to ( 5) , which is free of fatty acids.
本発明によれば、水中油乳化剤形の無機系の粉体を含有する皮膚外用剤において、その皮膚接着維持性を向上せしめる技術を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, in the skin external preparation containing the inorganic powder of an oil-in-water emulsifier form, the technique which improves the skin adhesion maintenance property can be provided.
(1)本発明の皮膚外用剤の必須成分であるアシル乳酸
本発明の皮膚外用剤は、アシル乳酸を必須成分として含有することを特徴とする。アシル乳酸を構成する、アシル基としては、炭素数8〜30の直鎖、分岐乃至は環状構造を有することあるアルキロイル基又はアルケロイル基が好ましく例示できる。この様なアシル基の具体的な例としては、例えば、2−エチルヘキサノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、イソステアロイル基、ベヘノイル基、オレオイル基、リノロイル基、リノレノイル基などが好適に例示できる。これらの内ではステアロイル乳酸が特に好ましい。かかるアシル乳酸は、ジメチルホルムアミドなどを反応溶媒として、乳酸と対応する酸クロリドとをピリジン乃至はトリエチルアミンなどのアルカリの存在下縮合させることにより得ることが出来る。前記酸クロリドは、脂肪酸と塩化チオニルなどのハロゲン化剤とを反応させることにより得ることが出来る。かかるアシル乳酸はそのまま使用することも出来るし、一部乃至は全部をアルカリ塩に誘導して使用することも出来る。これらの塩としては、皮膚外用剤で使用されるものであれば、特段の限定無く使用でき、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム塩、マグネシウム塩等のアルカリ土類金属塩、アンモニウム塩、トリエチルアミン塩、トリエタノールアミン塩、モノエタノールアミン塩等の有機アミン塩、リジン塩、アルギン酸塩等の塩基性アミノ酸塩等が好適に例示できる。特に好ましい塩はアルカリ金属塩であり、中でもナトリウム塩である。この様なアシル乳酸及び/又はその塩には、例えば、ステアロイル乳酸カルシウムのように食品添加物に指定されて市販されているものもの存するし、ステアロイル乳酸ナトリウムのように化粧料原料として市販されているものも存する。この様な市販品を購入して利用することも出来る。かかる成分は、乳化安定剤としての機能を有し、低粘度でありながら、無機系の粉体類の沈降を抑制する乳化構造を、後記のアシル化ポリグリセリンとともに形成する。この様な効果を奏するためには、かかるアシル乳酸は、1種乃至は2種以上を総量で、皮膚外用剤全量に対し、0.05〜5質量%、より好ましくは0.1〜1質量%含有することが好適である。
(1) Acyllactic acid which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing acyllactic acid as an essential component. Preferred examples of the acyl group constituting the acyl lactic acid include an alkyloyl group or an alkeroyl group having a linear, branched or cyclic structure having 8 to 30 carbon atoms. Specific examples of such acyl group include, for example, 2-ethylhexanoyl group, lauroyl group, myristoyl group, palmitoyl group, stearoyl group, isostearoyl group, behenoyl group, oleoyl group, linoloyl group, linolenoyl group. Etc. can be suitably exemplified. Of these, stearoyl lactic acid is particularly preferred. Such acyl lactic acid can be obtained by condensing lactic acid and the corresponding acid chloride in the presence of an alkali such as pyridine or triethylamine using dimethylformamide or the like as a reaction solvent. The acid chloride can be obtained by reacting a fatty acid with a halogenating agent such as thionyl chloride. Such acyl lactic acid can be used as it is, or a part or all of the acyl lactic acid can be derived from an alkali salt. These salts can be used without any particular limitation as long as they are used in skin external preparations, for example, alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts. Preferred examples include organic amine salts such as ammonium salt, triethylamine salt, triethanolamine salt, and monoethanolamine salt, and basic amino acid salts such as lysine salt and alginate. Particularly preferred salts are alkali metal salts, especially sodium salts. Examples of such acyl lactic acid and / or a salt thereof include those that are designated as food additives and marketed, such as calcium stearoyl lactate, and are marketed as cosmetic raw materials such as sodium stearoyl lactate. Some exist. Such commercial products can also be purchased and used. Such a component has a function as an emulsion stabilizer and forms an emulsified structure that suppresses sedimentation of inorganic powders while having a low viscosity together with an acylated polyglycerin described later. In order to exert such effects, the acyl lactic acid is a total of one or two or more kinds of acyl lactic acid, and is 0.05 to 5% by mass, more preferably 0.1 to 1% by mass with respect to the total amount of the external preparation for skin. % Content is preferred.
(2)本発明の皮膚外用剤の必須成分であるアシル化ポリグリセリン
本発明の皮膚外用剤は、必須成分としてアシル化ポリグリセリンを含有することを特徴とする。前記アシル化ポリグリセリンを構成するアシル基としては、炭素数8〜30の直鎖、分岐乃至は環状構造を有することあるアルキロイル基又はアルケロイル基が好ましく例示できる。この様なアシル基の具体的な例としては、例えば、2−エチルヘキサノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、イソステアロイル基、ベヘノイル基、オレオイル基、リノロイル基、リノレノイル基などが好適に例示できる。これらの中ではステアロイル基が特に好ましい。又、ポリグリセリンとしては、重合度5〜15のポリグリセリンが好ましく、7〜12が特に好ましい。かかるポリグリセ
リンのフリーの水酸化の内、前記アシル基で修飾されるものは半分以下であることが好ましく、少なくとも複数のアシル基を同一分子内に有することが好ましい。具体的には、本発明の皮膚外用剤では、ペンタアシル化デカグリセリン、テトラアシル化デカグリセリン、テトラアシル化オクタグリセリンなどが好適に例示できる。この様なアシル化ポリグリセリンは唯一種を含有することも出来るし、二種以上を組み合わせて含有させることも出来る。かかる成分は、本発明の皮膚外用剤においては、前記アシル乳酸とともに働いて、低粘度でありながら、無機系の粉体類の沈降を抑制する乳化構造を形成する。この様な効果を奏するためには、かかるアシル化ポリグリセリンを、皮膚外用剤全量に対して、総量で0.1〜10質量%、より好ましくは0.2〜2質量%含有させることが好ましい。又、かかるアシル化ポリグリセリンとアシル乳酸との質量比は、1:1〜5:1が特に好ましい。かかるアシル化ポリグリセリンと、アシル乳酸及び/又はその塩とを作用させて、低粘度で、安定な乳化構造を形成させるためには、アシル化ポリグリセリン、アシル乳酸、及び、ベヘニルアルコールやセチルアルコールなどの高級アルコールとを加温して相溶させ、これに水酸化ナトリウム水溶液などのアルカリ水溶液を添加して、プレミックスを作製し、かかるプレミックスにその他の成分を加えて調整することが、より低粘度で、安定性の高い乳化構造が創出できるので好ましい。
(2) Acylated polyglycerin which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing acylated polyglycerin as an essential component. Preferred examples of the acyl group constituting the acylated polyglycerin include an alkyloyl group or alkeroyl group having a linear, branched or cyclic structure having 8 to 30 carbon atoms. Specific examples of such acyl group include, for example, 2-ethylhexanoyl group, lauroyl group, myristoyl group, palmitoyl group, stearoyl group, isostearoyl group, behenoyl group, oleoyl group, linoloyl group, linolenoyl group. Etc. can be suitably exemplified. Of these, stearoyl groups are particularly preferred. Moreover, as polyglycerol, the polyglycerol of 5-15 of a polymerization degree is preferable, and 7-12 are especially preferable. Of such free hydroxylation of polyglycerin, those modified with the acyl group are preferably half or less, and preferably have at least a plurality of acyl groups in the same molecule. Specifically, in the skin external preparation of the present invention, pentaacylated decaglycerin, tetraacylated decaglycerin, tetraacylated octaglycerin and the like can be suitably exemplified. Such an acylated polyglycerin can contain only one species, or a combination of two or more species. In the external preparation for skin of the present invention, such an ingredient works together with the acyllactic acid to form an emulsified structure that suppresses sedimentation of inorganic powders while having low viscosity. In order to exert such effects, the acylated polyglycerin is preferably contained in a total amount of 0.1 to 10% by mass, more preferably 0.2 to 2% by mass, based on the total amount of the external preparation for skin. . The mass ratio of the acylated polyglycerin and the acyl lactic acid is particularly preferably 1: 1 to 5: 1. In order to make such an acylated polyglycerin and acyl lactic acid and / or a salt thereof act to form a stable emulsion structure with low viscosity, acylated polyglycerin, acyl lactic acid, behenyl alcohol, cetyl alcohol, etc. It is possible to make a premix by adding an aqueous alkali solution such as an aqueous sodium hydroxide solution to the other higher alcohol, and then adjusting the premix by adding other ingredients. This is preferable because an emulsion structure having low viscosity and high stability can be created.
(3)本発明の皮膚外用剤の必須成分である無機系の粉体
本発明の皮膚外用剤は、必須成分として、表面を親油化処理されていても良い、無機系の粉体を5〜30質量%、より好ましくは10〜25質量%含有することを特徴とする。かかる無機系の粉体としては、マイカ、タルク、セリサイト、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛等の無機顔料類、雲母チタン、オキシ塩化ビスマス等のパール剤類などが挙げられる。これらの無機系の粉体は、表面処理をしない形でも、表面処理した形でも含有せしめることが出来るが、親油化処理を施して含有させることが、分散性を更に向上させるので好ましい。又、本発明では、この様な無機系の粉体の内に、ヒドロキシアパタイトを含む被覆層を有する無機系の粉体を含有することを必須とする。ヒドロキシアパタイトを含む被覆層を有する無機系の粉体の製法は、特許文献11或いは特許文献12に開示されており、かかる文献の記載に従って製造することが出来る。即ち、水可溶性カルシウム塩の水溶液中に基体となる無機系の粉体を分散させ、これにリン酸を加えてヒドロキシアパタイトを析出させ、基体となる無機系の粉体上に沈積させたり、基体となる無機系の粉体と、微粒子ヒドロキシアパタイトとを水可溶性カルシウム塩水溶液中に分散させ、これにリン酸を加えて、ヒドロキシアパタイトを基体となる無機系の粉体と、ヒドロキシアパタイトの微粉末の表面とに析出させ、析出したヒドロキシアパタイトをバインダーとして、被覆層を構築する方法などである。又、かかる被覆層には、ヒドロキシアパタイト以外に、酸化亜鉛、シリカ、アルミナ、チタニアなどの金属酸化物を含有することが出来る。被覆層におけるヒドロキシアパタイトの含有量は50質量%以上であることが好ましい。この様な方法により、ヒドロキシアパタイトを含む被覆層を有する無機系の粉体を調整し、用いることも出来るが、既に市販されているヒドキシアパタイトを含む被覆層を有する粉体を購入して利用することも出来る。この様な市販のヒドロキシアパタイトを含む被覆層を有する無機系の粉体としては、「パウダー・ラ・ヴィ」(三好化成株式会社製;ヒドロキシアパタイト15質量部と酸化亜鉛5質量部とでセリサイト80質量部を被覆した粉体)が好ましく例示できる。本発明の皮膚外用剤では、この様なヒドロキシアパタイトを含有する被覆層を有する無機系の粉体を、皮膚外用剤全量に対して、0.01〜1質量%含
有することが好ましく、0.05〜0.5質量%含有することがより好ましい。かかる成分は、脂肪酸を吸着し、皮膚外用剤組成物の皮膚接着維持性阻害要因を抑制するが、前記の含有量で有効なのは本発明の皮膚外用剤の系が実質的に脂肪酸乃至はその塩を含有する必要がないため、接着維持性の低下の原因となる脂肪酸乃至はその塩は、生体由来のもののみであり、吸着すべき脂肪酸量としては少ないからである。尚、かかるヒドロキシアパタイトを含む被覆層を有する無機系の粉体における、被覆に用いられるヒドロキシアパタイト量は、この様な無機系の粉体の総量に対して、1〜30質量%が好ましく、より好ましくは、5〜20質量%である。又、基体となる無機系の粉体は、上記した各種の無機系の粉体が使用できるが、中でもマイカ、セリサイト、タルク、チタンマイカ、チタンセリサイト、他の金属酸化物をドープしていたり、焼結していても良い、二酸化チタン、酸化亜鉛、ベンガラ、黄色酸化鉄などが好適に例示できる。これらの中では、マイカ、セリサイト、タルクなどの板状粉体が特に好ましい。これらの製造例は後記に示す。
(3) Inorganic powder which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention contains 5 inorganic powder whose surface may be lipophilically treated as an essential component. It is characterized by containing -30 mass%, more preferably 10-25 mass%. Such inorganic powders include mica, talc, sericite, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc., bengara, yellow iron oxide Inorganic pigments such as black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide and zinc oxide, and pearl agents such as titanium mica and bismuth oxychloride. These inorganic powders can be contained either in a form that is not subjected to surface treatment or in a form that is subjected to surface treatment. However, it is preferable that the inorganic powder is contained after subjecting it to a lipophilic treatment because dispersibility is further improved. In the present invention, within the powder of such inorganic and essential and that it contains an inorganic powder having a coating layer comprising hydroxyapatite. A method for producing an inorganic powder having a coating layer containing hydroxyapatite is disclosed in Patent Document 11 or Patent Document 12, and can be produced according to the description of such a document. That is, an inorganic powder serving as a substrate is dispersed in an aqueous solution of a water-soluble calcium salt, and phosphoric acid is added thereto to precipitate hydroxyapatite, which is then deposited on the inorganic powder serving as a substrate. and inorganic powder which becomes, and a particulate hydroxyapatite dispersed in a water-soluble calcium salt solution, and added with phosphoric acid, and an inorganic powder comprising hydroxyapatite and a substrate, a fine powder of hydroxyapatite And a method of constructing a coating layer using the precipitated hydroxyapatite as a binder. In addition to hydroxyapatite, the coating layer can contain metal oxides such as zinc oxide, silica, alumina, and titania. The content of hydroxyapatite in the coating layer is preferably 50% by mass or more. In this way, inorganic powder having a coating layer containing hydroxyapatite can be prepared and used. However, a commercially available powder having a coating layer containing hydroxyapatite can be purchased and used. You can also As an inorganic powder having a coating layer containing such a commercially available hydroxyapatite, “powder la vi” (manufactured by Miyoshi Chemical Co., Ltd .; hydroxyapatite 15 parts by mass and zinc oxide 5 parts by mass is sericite. A preferred example is a powder coated with 80 parts by mass. In the external preparation for skin of the present invention, it is preferable to contain 0.01 to 1% by mass of such inorganic powder having a coating layer containing hydroxyapatite with respect to the total amount of external preparation for skin. It is more preferable to contain 05-0.5 mass%. Such a component adsorbs fatty acid and suppresses the skin adhesion maintenance inhibiting factor of the skin external preparation composition. However, the above-mentioned content is effective when the system of the skin external preparation of the present invention is substantially fatty acid or a salt thereof. This is because the fatty acid or salt thereof that causes a decrease in adhesion maintenance is only derived from a living body and the amount of fatty acid to be adsorbed is small. The amount of hydroxyapatite used for coating in the inorganic powder having a coating layer containing such hydroxyapatite is preferably 1 to 30% by mass with respect to the total amount of such inorganic powder. Preferably, it is 5-20 mass%. Further, the powder of the inorganic system comprising a substrate, various inorganic powders described above can be used, inter alia mica, sericite, talc, titanium mica, titanium sericite, not doped with other metal oxides or, sintered may Tei, titanium dioxide, zinc oxide, red iron oxide, such as yellow iron oxide can be suitably exemplified. Among these, plate-like powders such as mica, sericite, and talc are particularly preferable. These production examples will be described later.
前記無機系の粉体における、ヒドロキシアパタイトを含む被覆層を有する無機系の粉体以外の無機系の粉体において、前記親油化処理としては、通常化粧料などの皮膚外用剤用の粉体で行われている処理であれば特段の限定無く、例えば、N−アシルアミノ酸塩被覆処理、メチルハイドロジェンポリシロキサン焼付処理或いはアルキルアルコキシシランによるシランカップリング処理が好適に例示できる。かかる表面処理は唯一種の処理でも構わないし、2種以上の処理を施しても構わない。特に好ましい処理は、少なくともN−アシルアミノ酸塩で被覆処理した形態である。該N−アシルアミノ酸塩としては、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、イソステアロイル基、オレオイル基など、アシル基として炭素数10〜30の脂肪族のアシル基を好ましく有し、アミノ酸部分としては、リジン残基乃至はグルタミン酸残基を好ましく有し、塩としては、アルミニウム塩乃至は亜鉛塩を好ましく採用するものである。具体的な例示としては、N−ラウロイルグルタミン酸アルミニウム塩、N−ラウロイルグリシンアルミニウム塩、N−ラウロイルグルタミン酸亜鉛塩、N−ラウロイルグリシン亜鉛塩、N−ステアロイルグルタミン酸アルミニウム塩、N−ステアロイルグルタミン酸亜鉛塩等が好適に例示でき、N−ラウロイルグルタミン酸アルミニウム塩が特に好適に例示できる。この様なN−アシルアミノ酸塩の被覆は、例えば、N−ステアロイルグルタミン酸アルミニウム被覆を例に取れば、N−ステアロイルグルタミン酸ナトリウムの水溶液に無機系の粉体を分散させ、しかる後、かかる無機系の粉体に、塩化アルミニウムの水溶液を添加し、N−ステアロイルグルタミン酸アルミニウムを無機系の粉体上に沈着させればよい。かかる表面処理は、無機系の粉体の質量に対し、1〜20%の質量の被覆を行うことが適当である。以下に製造例を示す。 The powder of the inorganic, the inorganic mineral-based powder other than powder having a coating layer including hydroxyapatite, as the lipophilic treatment, the powder for a skin external preparation such as normal cosmetics For example, N-acyl amino acid salt coating treatment, methyl hydrogen polysiloxane baking treatment, or silane coupling treatment with alkylalkoxysilane can be suitably exemplified. Such surface treatment may be a single type of treatment or two or more types of treatment. A particularly preferable treatment is a form coated with at least an N-acylamino acid salt. The N-acyl amino acid salt preferably has an aliphatic acyl group having 10 to 30 carbon atoms as an acyl group, such as lauroyl group, myristoyl group, palmitoyl group, stearoyl group, isostearoyl group, oleoyl group, and the like. The portion preferably has a lysine residue or a glutamic acid residue, and the salt preferably employs an aluminum salt or a zinc salt. Specific examples include N-lauroyl glutamic acid aluminum salt, N-lauroyl glycine aluminum salt, N-lauroyl glutamic acid zinc salt, N-lauroyl glycine zinc salt, N-stearoyl glutamic acid aluminum salt, N-stearoyl glutamic acid zinc salt and the like. Preferable examples include N-lauroylglutamic acid aluminum salt. Such N-acyl amino acid salt coating is, for example, an aluminum N-stearoyl glutamate coating as an example. An inorganic powder is dispersed in an aqueous solution of sodium N-stearoyl glutamate . An aqueous solution of aluminum chloride may be added to the powder, and aluminum N-stearoyl glutamate may be deposited on the inorganic powder. For this surface treatment, it is appropriate to perform the coating at a mass of 1 to 20% with respect to the mass of the inorganic powder. Production examples are shown below .
<製造例1>親油化処理粉体の製造例
二酸化チタン100gを500mlの1%N−ステアロイルグルタミン酸ナトリウム水溶液に分散させ、これに125mlの1%塩化アルミニウム水溶液を加え、緩やかに4時間攪拌し、N−ステアロイルグルタミン酸アルミニウムを二酸化チタン表面に沈積させた。反応終了後遠心分離(3000g、10分)して上清を捨て、更に1000mlの水を加え、攪拌した後、遠心分離し、洗浄する作業を3回行った。沈殿した粉体を乾燥させ、擂壊機で壊砕し、1mmヘリングボーンスクリーンを装着したパルベライザーで粉砕し、N−ステアロイルグルタミン酸アルミニウム被覆二酸化チタンである粉体1を得た。
<Production Example 1> Production Example of Lipophilicized Powder 100 g of titanium dioxide was dispersed in 500 ml of 1% N-stearoyl sodium glutamate aqueous solution, 125 ml of 1% aluminum chloride aqueous solution was added thereto and gently stirred for 4 hours. N-stearoyl glutamate aluminum was deposited on the titanium dioxide surface. After completion of the reaction, the mixture was centrifuged (3000 g, 10 minutes), and the supernatant was discarded. Further, 1000 ml of water was added, stirred, centrifuged, and washed three times. The precipitated powder was dried, crushed with a breaker, and pulverized with a pulverizer equipped with a 1 mm herringbone screen to obtain a powder 1 which was titanium dioxide coated with N-stearoyl glutamate.
<製造例2>親油化処理粉体の製造例
二酸化チタンをベンガラに代えて、同様に処置し、粉体2を得た。
<Manufacture example 2> Manufacture example of lipophilic processing powder The titanium dioxide was replaced with the bengara and it processed in the same way, and the powder 2 was obtained.
<製造例3>親油化処理粉体の製造例
二酸化チタンを黄色酸化鉄に代えて、同様に処置し、粉体3を得た。
<Manufacture example 3> Manufacture example of lipophilic treatment powder Titanium dioxide was replaced with yellow iron oxide, and it treated similarly and obtained powder 3.
<製造例4>親油化処理粉体の製造例
二酸化チタンをタルクに代えて、同様に処置し、粉体4を得た。
<Manufacture example 4> Manufacture example of lipophilic processing powder The titanium dioxide was replaced with talc and it processed similarly and obtained the powder 4.
<製造例5>ヒドロキシアパタイト被覆層を有する粉体の製造例
燐酸二アンモニウム85.2gを水4.5lに溶かして溶液とし、これにセリサイト1Kgを加え均一に分散させた。次に、攪拌冷却下、アンモニア水を徐々に添加して系のpHを9.0に調整し、硝酸カルシウム156.1gを水500mlに溶かした溶液を徐々に加えた。添加終了後、さらに1時間攪拌を続け、得られたスラリーを遠心分離(3000g、10分)し、上清を捨て、再度2lの水を加えて分散させて、遠心分離し、洗浄した。この洗浄作業は3回行った。その後、遠心分離して脱水した粉体を110℃の温度で乾燥してヒドロキシアパタイト被覆(約2質量%)セリサイト(粉体5)を得た。
<Production Example 5> Production Example of Powder Having Hydroxyapatite Coating Layer 85.2 g of diammonium phosphate was dissolved in 4.5 l of water to form a solution, and 1 kg of sericite was added thereto and dispersed uniformly. Next, with stirring and cooling, aqueous ammonia was gradually added to adjust the pH of the system to 9.0, and a solution prepared by dissolving 156.1 g of calcium nitrate in 500 ml of water was gradually added. After completion of the addition, the mixture was further stirred for 1 hour, and the resulting slurry was centrifuged (3000 g, 10 minutes). The supernatant was discarded, and 2 l of water was added again to disperse, followed by centrifugation and washing. This washing operation was performed three times. Thereafter, the dehydrated powder by centrifugation was dried at a temperature of 110 ° C. to obtain hydroxyapatite-coated (about 2 mass%) sericite (powder 5).
<製造例6>ヒドロキシアパタイト被覆層を有する粉体の製造例
製造例5と同様の操作で、セリサイトをマイカに置換して処理し、ヒドロキシアパタイト被覆(約2質量%)マイカ(粉体6)を得た。
<Production Example 6> Production Example of Powder Having Hydroxyapatite Coating Layer In the same manner as in Production Example 5, sericite was replaced with mica and treated to produce hydroxyapatite coating (about 2% by mass) mica (powder 6). )
<製造例7>ヒドロキシアパタイト被覆層を有する粉体の製造例
製造例5と同様の操作で、セリサイトをタルクに置換して処理し、ヒドロキシアパタイト被覆(約2質量%)タルク(粉体7)を得た。
<Production Example 7> Production Example of Powder Having Hydroxyapatite Coating Layer In the same manner as in Production Example 5, sericite is replaced with talc and treated to produce hydroxyapatite coating (about 2% by mass) talc (powder 7 )
(4)本発明の皮膚外用剤の必須成分である硫酸系アニオン界面活性剤
本発明の皮膚外用剤は、硫酸系アニオン界面活性剤として脂肪酸グリセリン硫酸塩を必須成分として含有することを特徴とする。該脂肪酸グリセリン硫酸エステル塩を構成する脂肪酸残基(アシル基)としては、炭素数10〜30のものが好ましく、例えば、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、イソステアロイル基、ベヘノイル基、オレオイル基などが好適に例示でき、これらの天然混合物であるヤシ油脂肪酸残基、牛脂脂肪酸残基、パーム油脂肪酸残基などを使用することも出来る。中でもヤシ油脂肪酸グリセリル硫酸エステル塩が最も好ましい。これらの塩としては、皮膚外用剤で使用されるものであれば、特段の限定無く使用でき、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム塩、マグネシウム塩等のアルカリ土類金属塩、アンモニウム塩、トリエチルアミン塩、トリエタノールアミン塩、モノエタノールアミン塩等の有機アミン塩、リジン塩、アルギン酸塩等の塩基性アミノ酸塩等が好適に例示できる。特に好ましい塩はアルカリ金属塩であり、中でもナトリウム塩である。かかる成分は、親油化されていても良い無機系の粉体の、系への分散性を向上せしめ、チキソトロピー性を低減させる作用を有する。この様な効果を奏するためには、前記脂肪酸グリセリン硫酸塩から選択される1種乃至は2種以上を、0.05〜0.5質量%で含有する。これは少なすぎると前記効果を奏しない場合が存し、多すぎると系の安定性を損なう場合が存するからであ
る。
(4) Sulfate-based anionic surfactant that is an essential component of the skin external preparation of the present invention The skin external preparation of the present invention is characterized by containing fatty acid glycerin sulfate as an essential component as a sulfate-based anionic surfactant. The The fatty acid residue (acyl group) constituting the fatty acid glycerol sulfate ester salt is preferably those having 10 to 30 carbon atoms, such as lauroyl group, myristoyl group, palmitoyl group, stearoyl group, isostearoyl group, behenoyl group, An oleoyl group and the like can be suitably exemplified, and coconut oil fatty acid residues, beef tallow fatty acid residues, palm oil fatty acid residues and the like which are natural mixtures thereof can also be used. Of these, coconut oil fatty acid glyceryl sulfate is most preferable. These salts can be used without any particular limitation as long as they are used in skin external preparations, for example, alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts. Preferred examples include organic amine salts such as ammonium salt, triethylamine salt, triethanolamine salt, and monoethanolamine salt, and basic amino acid salts such as lysine salt and alginate. Particularly preferred salts are alkali metal salts, especially sodium salts. Such components have the effect of improving the dispersibility of the inorganic powder, which may be oleophilic, in the system and reducing the thixotropy. In order to achieve such an effect, one or more selected from the fatty acid glycerin sulfates may be used as 0 . It contained at 05 to 0.5 wt%. This is because if the amount is too small, the above-described effect may not be achieved, and if the amount is too large, the stability of the system may be impaired.
(5)本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須成分を含有し、水中油乳化剤形であることを特徴とする。かかる水中油乳化剤形は、最外相が水相である乳化剤形の総称であり、水中油中水(W/O/W)剤形等の複合多層剤形も包含する。本発明の皮膚外用剤としては、皮膚に外用で投与されるものであれば特段の限定無く適用でき、例えば、医薬部外品を包含する化粧料、皮膚外用医薬、皮膚外用雑貨などが好適に例示できる。特に好ましいものは、化粧料である。これは無機系の粉体の応用範囲が広いためである。
(5) the external preparation for skin of the external preparation for skin of the Invention The present invention contain the essential components, wherein the oil-in-water emulsion formulations. Or mow oil emulsifier forms, outermost phase is the generic name for emulsifier type is the aqueous phase, also encompasses composite multilayer dosage forms, such as water-in-oil-in-water (W / O / W) dosage form. The external preparation for skin of the present invention can be applied without particular limitation as long as it is administered externally to the skin. For example, cosmetics including quasi-drugs, external preparations for skin, and general-purpose items for external use are suitable. It can be illustrated. Particularly preferred are cosmetics. This is because the application range of inorganic powder is wide.
本発明の皮膚外用剤には、前記必須成分以外に、通常化粧料などの皮膚外用剤で使用される任意の成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセ
リン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)等の硫酸系アニオン界面活性剤に分類されないアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、魚燐箔等の有機パール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB 6 塩酸塩、ビタミンB 6 トリパルミテート、ビタミンB 6 ジオクタノエート、ビタミンB 2 又はその誘導体、ビタミンB 12 、ビタミンB 15 又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。中でも、粉体の分散性を更に向上させるために、アルキレンオキシド変性シリコーン及び/又はグリセリン変性シリコーンを含有することが好ましい。かかる成分の好ましい含有量は、総量で、皮膚外用剤全量に対して、好ましくは、0.01〜1質量%、より好ましくは、0.05〜0.5質量%である。かかる必須成分と任意成分と
を常法に従って処理することにより、本発明の皮膚外用剤は製造できる。
The external preparation for skin of the present invention can contain any component that is usually used in external preparations for skin such as cosmetics in addition to the essential components. Examples of such optional ingredients include macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, and hardened coconut oil. Oil, wax, oils such as beeswax, molasses, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax; , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpoly Linear polysiloxanes such as oxane and diphenylpolysiloxane; cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oils such as modified polysiloxanes such as fluorine-modified polysiloxanes; Anionic surfactants not classified as sulfuric acid anionic surfactants such as fatty acid soaps (sodium laurate, sodium palmitate, etc.); stearyltrimethyl chloride Cationic surfactants such as ammonium, benzalkonium chloride and laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide- 1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), and amphoteric surfactants such as acylmethyltaurine; sorbitan fatty acid esters (sorbitan monostearate, sesquiskies) Sorbitan oleate, etc.), glycerin fatty acids (eg glyceryl monostearate), propylene glycol fatty acid esters (eg propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monoole) Acid, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin) Monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl ether, etc.), Pluronic type , POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid ester, alkyl Nonionic surfactants such as glucoside; polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol Polyhydric alcohols such as coal, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol; sodium pyrrolidonecarboxylate, lactic acid, lactic acid moisturizing ingredients such as sodium; but it may also have been surface treated, organic pearl agents such as fish phosphorus foil; good red No. 202 be laked, red No. 228, red No. 226, yellow No. 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213, Yellow 204, Yellow 203, Blue 1, Green 201, Purple 201, Red 204 Organic dyes such as polyethylene powder; organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer; Benzoic acid UV absorbers; anthranilic acid UV absorbers; salicylic acid UV absorbers; cinnamic acid UV absorbers; benzophenone UV absorbers; sugar UV absorbers; 2- (2'-hydroxy- UV absorbers such as 5′-t-octylphenyl) benzotriazole and 4-methoxy-4′-t-butyldibenzoylmethane; lower alcohols such as ethanol and isopropanol; vitamin A or a derivative thereof, vitamin B 6 hydrochloric acid Vitamin Bs such as salt, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or derivatives thereof, vitamin B 12 , vitamin B 15 or derivatives thereof; α-tocopherol, β-tocopherol, γ-tocopherol, vitamin Vitamin E such as E acetate, vitamin D, vitamin H, pantothenic acid, Preferred examples include vitamins such as pantethine and pyrroloquinoline quinone; and antibacterial agents such as phenoxyethanol. Among these, in order to further improve the dispersibility of the powder, it is preferable to contain an alkylene oxide-modified silicone and / or a glycerin-modified silicone. The total content of such components is preferably 0.01 to 1% by mass, and more preferably 0.05 to 0.5% by mass, based on the total amount of the external preparation for skin. The skin external preparation of this invention can be manufactured by processing this essential component and an arbitrary component according to a conventional method.
以下に、本発明について、実施例を挙げて更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, the present invention will be described in more detail with reference to examples, but it is needless to say that the present invention is not limited to such examples.
以下に示す処方に従って、本発明の皮膚外用剤である、ファンデーション(メークアップ化粧料)を作製した。即ち、処方成分イ、ロ、ハをそれぞれ80℃に加温し、一様に混合し、攪拌下イに徐々にロを加え、これに更に、ニを加え、デイスパーで分散させ、これに攪拌下ハを徐々に加え、攪拌冷却し、水中油乳化剤形の化粧料1を得た。同様に操作して、「ニッコールSGC−80N」をセチル乳酸ナトリウムに置換した比較例1、デカグリセリンペンタステアリン酸エステルをPOE(2)ステアリン酸エステルに置換した比較例2、セチル乳酸ナトリウムを「ニッコールSGC−80N」に置換した比較例3も作製し、20℃に24時間保存して、恒量化した後、外観で性状を、顕微鏡観察(300倍)で乳化状態(平均粒子径;μm)と粉体分散性(5視野における100μm以上の径を有する粉体の固まりの個数の総和;個)と粘度(B型粘度計4号ローター毎分12回転;mPa・s)を観察した。加えて、40℃に1ヶ月保存し、外観の性状も併せて検討した。結果を表2に示す。これより、本発明の皮膚外用剤は、粉体分散性に優れ、使用性にも優れることがわかる。 In accordance with the formulation shown below, a foundation (make-up cosmetic), which is an external preparation for skin of the present invention, was prepared. That is, prescription ingredients A, B, and C are each heated to 80 ° C., uniformly mixed, gradually added to B under stirring, further added with D, dispersed with a disperser, and stirred. Lower water was gradually added, and the mixture was stirred and cooled to obtain a cosmetic 1 in the form of an oil-in-water emulsifier. In the same manner, Comparative Example 1 in which “Nikkol SGC-80N” was substituted with sodium cetyl lactate, Comparative Example 2 in which decaglycerin pentastearate was substituted with POE (2) stearate, Comparative Example 3 substituted with “SGC-80N” was also prepared, stored at 20 ° C. for 24 hours, and constant weighted. Then, the appearance was characterized by an emulsified state (average particle diameter; μm) by microscopic observation (300 times). The powder dispersibility (the total number of masses of powders having a diameter of 100 μm or more in five fields of view; pieces) and the viscosity (B-type viscometer No. 4 rotor, 12 revolutions per minute; mPa · s) were observed. In addition, it was stored at 40 ° C. for 1 month, and the appearance properties were also examined. The results are shown in Table 2. From this, it can be seen that the external preparation for skin of the present invention has excellent powder dispersibility and excellent usability.
<試験例2>
化粧料1の「パウダー・ラ・ヴィ」の効果を確認するために、化粧料1の「パウダー・ラ・ヴィ」をセリサイトに置換して、比較例4を作製し、皮膚接着性試験を行った。即ち、前処理をしない前腕内側部に2cm×4cmの部位を2つ作製し、片方の部位には化粧料1の40μlを、他方の部位には比較例4の40μlをガラス棒で塗布し、10分間静置し、コニカミノルタ色彩色差計CR400で標準白色板に対する色差を測定し、温流水下に2分置き、しかる後に軽くペーパータオルで水分をぬぐい、10分間静置し、再度標準白色板に対する色差を測定した。温流水処置の前後の色差を算出し、その色差の小ささを皮膚接着性の良さとして評価した。化粧料1の処置による色差(ΔE)は0.32であり、比較例4の色差(ΔE)は0.67であった。ヒドロキシアパタイトを含有する被覆層を有する粉体の効果が確認された。
<Test Example 2>
In order to confirm the effect of “powder la vi” of cosmetic 1, replace “powder la vi” of cosmetic 1 with sericite to prepare Comparative Example 4 and conduct a skin adhesion test. went. That is, two 2 cm × 4 cm portions were prepared on the inner part of the forearm without pretreatment, 40 μl of cosmetic 1 was applied to one portion with 40 μl of Comparative Example 4 with a glass rod, Allow to stand for 10 minutes, measure the color difference with a Konica Minolta color difference meter CR400 against a standard white plate, place under warm running water for 2 minutes, then lightly wipe with a paper towel, leave for 10 minutes, and again against the standard white plate The color difference was measured. The color difference before and after the warm water treatment was calculated, and the small color difference was evaluated as good skin adhesiveness. The color difference (ΔE) due to the treatment of the cosmetic 1 was 0.32, and the color difference (ΔE) of Comparative Example 4 was 0.67. The effect of the powder having a coating layer containing hydroxyapatite was confirmed.
化粧料1のN−ステアロイルグルタミン酸アルミニウム処理粉体を通常の粉体に置換して、実施例1と同様にファンデーション(化粧料2)を作製した。このものは20℃、40℃1ヶ月の保存後でも外観に異常は認められず、平均乳化粒子径は1.7μmであり、粉体分散性は、粉体塊が3個(5視野合計)であり、粘度は7200mPa・sであった。本発明の皮膚外用剤には、通常の粉体も使用可能であることが確認されたが、粉体としては、少なくともN−ステアロイルグルタミン酸アルミニウムで表面処理されたものが好ましいこともわかる。又、化粧料2は試験例2の評価では、色差(ΔE)が0.38であった。皮膚接着性維持性の向上も確認された。 A foundation (cosmetics 2) was prepared in the same manner as in Example 1 by replacing the N-stearoyl aluminum glutamate treated powder of cosmetic 1 with a normal powder. No abnormalities were observed in the appearance even after storage at 20 ° C. and 40 ° C. for 1 month, the average emulsified particle size was 1.7 μm, and the powder dispersibility was 3 powder agglomerates (total of 5 fields) And the viscosity was 7200 mPa · s. Although it was confirmed that a normal powder can be used for the external preparation for skin of the present invention, it is also understood that a powder that has been surface-treated with at least aluminum N-stearoyl glutamate is preferable. Further, in the evaluation of Test Example 2, the cosmetic 2 had a color difference (ΔE) of 0.38. It was also confirmed that skin adhesion maintenance was improved.
実施例1と同様に下記に示す処方に従って、化粧料3〜5を作製し、試験例2の方法に従って評価した。結果を表5に示す。何れのヒドロキシアパタイトを含有する被覆層を有する粉体も、皮膚接着維持性向上効果を有していた。 In the same manner as in Example 1, cosmetics 3 to 5 were prepared according to the formulation shown below and evaluated according to the method of Test Example 2. The results are shown in Table 5. The powder having a coating layer containing any hydroxyapatite had an effect of improving skin adhesion maintenance.
本発明は、化粧料などの皮膚外用剤に応用できる。 The present invention can be applied to external preparations for skin such as cosmetics.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006308597A JP5086612B2 (en) | 2006-11-15 | 2006-11-15 | Emulsified skin external preparation containing hydroxyapatite-treated powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006308597A JP5086612B2 (en) | 2006-11-15 | 2006-11-15 | Emulsified skin external preparation containing hydroxyapatite-treated powder |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008120757A JP2008120757A (en) | 2008-05-29 |
JP2008120757A5 JP2008120757A5 (en) | 2009-12-24 |
JP5086612B2 true JP5086612B2 (en) | 2012-11-28 |
Family
ID=39505898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006308597A Active JP5086612B2 (en) | 2006-11-15 | 2006-11-15 | Emulsified skin external preparation containing hydroxyapatite-treated powder |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5086612B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2517111C2 (en) * | 2009-09-30 | 2014-05-27 | Кабусики Кайся Санги | Method of increasing water solubility of low-solubility substances |
JP5909796B2 (en) | 2012-03-02 | 2016-04-27 | 株式会社サンギ | Method for improving water solubility of poorly soluble substances |
WO2024057859A1 (en) * | 2022-09-13 | 2024-03-21 | 株式会社タイキ | Oil-in-water type cosmetic |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4412081B4 (en) * | 1994-04-08 | 2006-10-19 | IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG | Polyglycerol ester-based emulsifier and sunscreen emulsion containing the same |
JP3523942B2 (en) * | 1995-08-04 | 2004-04-26 | 日光ケミカルズ株式会社 | O / W emulsion type cosmetics |
JPH10194964A (en) * | 1997-01-06 | 1998-07-28 | Pola Chem Ind Inc | Emulsion composition |
JPH11269049A (en) * | 1998-03-23 | 1999-10-05 | Yakult Honsha Co Ltd | O/w emulsion type sunscreen preparation |
JP3682614B2 (en) * | 1998-08-19 | 2005-08-10 | 株式会社コーセー | Aqueous cosmetics |
JP3860701B2 (en) * | 2000-02-09 | 2006-12-20 | 株式会社コーセー | Solid powder cosmetic for water use |
JP3822782B2 (en) * | 2000-07-06 | 2006-09-20 | 三好化成株式会社 | Sebum-adsorbing powder and use thereof |
JP4225717B2 (en) * | 2001-09-21 | 2009-02-18 | 花王株式会社 | Cosmetics |
JP3727901B2 (en) * | 2001-09-27 | 2005-12-21 | 株式会社コーセー | Oil-in-water emulsified cosmetic |
JP4965807B2 (en) * | 2005-03-30 | 2012-07-04 | 日光ケミカルズ株式会社 | Composition for external use and external preparation for skin containing the same |
-
2006
- 2006-11-15 JP JP2006308597A patent/JP5086612B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008120757A (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010168302A (en) | Emulsified cosmetic | |
JP2009084232A (en) | Emulsion formulation-type powder-containing external preparation for skin | |
JP6640520B2 (en) | Oil-in-water emulsion composition | |
JP2008297238A (en) | Water-in-oil emulsion type powder-containing external preparation for skin | |
JP2008143836A (en) | Surface-treated powder and cosmetic containing the surface-treated powder | |
JP5827079B2 (en) | Powder-containing skin external preparation | |
JP5086612B2 (en) | Emulsified skin external preparation containing hydroxyapatite-treated powder | |
JP5086611B2 (en) | Powder-containing emulsified skin external preparation | |
KR20200011434A (en) | Cosmetics | |
JP2008120756A5 (en) | ||
JP2008120755A (en) | Emulsified skin external preparation containing low-viscosity powder | |
JP2008120757A5 (en) | ||
JP2009040738A (en) | Water-in-oil emulsifier type external preparation for skin | |
JP5201658B2 (en) | Multi-layer treated powder-containing aqueous skin preparation | |
JP2008255044A5 (en) | ||
JP5367257B2 (en) | Powder-containing emulsifier type skin external preparation | |
JP2008297239A (en) | Water-in-oil type external preparation for skin | |
JP2008255044A (en) | External preparation for skin in the form of emulsifier type | |
JP3308555B2 (en) | Method for producing finely divided emulsion composition | |
JP5491742B2 (en) | Makeup cosmetics | |
JP4960004B2 (en) | Ubidecalenone-containing cosmetic in vesicle dispersion dosage form | |
JP5653401B2 (en) | Method for producing powder-containing external preparation for skin containing emulsifier | |
JP2008150329A (en) | Skin care preparation, suitable for cosmetic | |
JP2007001867A5 (en) | ||
JP2006022000A (en) | Oil-cleansing cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091111 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091111 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20091111 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110809 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110927 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120508 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120828 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120907 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5086612 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20180914 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |